6-160490876-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000335388.5(LPAL2):n.508+1905G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.442 in 151,940 control chromosomes in the GnomAD database, including 16,758 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.44 ( 16758 hom., cov: 32)
Consequence
LPAL2
ENST00000335388.5 intron
ENST00000335388.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.661
Publications
5 publications found
Genes affected
LPAL2 (HGNC:21210): (lipoprotein(a) like 2 (pseudogene)) Apolipoprotein(a) is the distinguishing protein moiety of lipoprotein(a), of which elevated plasma levels are correlated with an increased risk of atherosclerosis. This gene is similar to the lipoprotein, Lp(a) gene, but all transcripts produced by this gene contain a truncated open reading frame and are candidates for nonsense-mediated decay. Consequently, this gene is considered to be a pseudogene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.859 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LPAL2 | ENST00000335388.5 | n.508+1905G>A | intron_variant | Intron 3 of 9 | 1 | |||||
| LPAL2 | ENST00000435757.6 | n.508+1905G>A | intron_variant | Intron 3 of 9 | 1 | |||||
| LPAL2 | ENST00000719164.1 | n.1095G>A | non_coding_transcript_exon_variant | Exon 4 of 4 | ||||||
| LPAL2 | ENST00000454031.6 | n.549+487G>A | intron_variant | Intron 4 of 16 | 6 |
Frequencies
GnomAD3 genomes AF: 0.442 AC: 67141AN: 151822Hom.: 16737 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
67141
AN:
151822
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.442 AC: 67189AN: 151940Hom.: 16758 Cov.: 32 AF XY: 0.450 AC XY: 33391AN XY: 74216 show subpopulations
GnomAD4 genome
AF:
AC:
67189
AN:
151940
Hom.:
Cov.:
32
AF XY:
AC XY:
33391
AN XY:
74216
show subpopulations
African (AFR)
AF:
AC:
9150
AN:
41462
American (AMR)
AF:
AC:
8522
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
AC:
1740
AN:
3468
East Asian (EAS)
AF:
AC:
4545
AN:
5162
South Asian (SAS)
AF:
AC:
3179
AN:
4806
European-Finnish (FIN)
AF:
AC:
5073
AN:
10530
Middle Eastern (MID)
AF:
AC:
156
AN:
294
European-Non Finnish (NFE)
AF:
AC:
33337
AN:
67942
Other (OTH)
AF:
AC:
1040
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1751
3502
5252
7003
8754
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
630
1260
1890
2520
3150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2617
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.